Parth Desai (@parthde93098240) 's Twitter Profile
Parth Desai

@parthde93098240

Physician scientist in the making

ID: 1100556681837199362

calendar_today27-02-2019 00:42:15

25 Tweet

74 Followers

421 Following

Dr. Kimryn Rathmell (@ncidirector) 's Twitter Profile Photo

Depressing news in Small Cell Lung Cancer, a cancer where there has been almost no progress in 30+ years. But this is how Accelerated Approval should work: making an initially promising therapy available to patients until more definitive data become available. FDA Oncology

Parth Desai (@parthde93098240) 's Twitter Profile Photo

Honored to have received YIA Conquer Cancer, the ASCO Foundation . Sincere thanks to my mentor Dr Anish thomas from @NCIResearchCtr and my small cell lung cancer colleagues at NCI. Lastly much thanks to my wife and my family for their support! Hopefully we learn and benefit our patients. ASCO

Parth Desai (@parthde93098240) 's Twitter Profile Photo

The amazing attention dostarlimab trial in MSI-h rectal ca around the world from news outlets is very inspiring however we have to be cautious that this is done in a very selected population of patients with a know recipe to get IO benefits with a very short fu period.#ASCO2022

Parth Desai (@parthde93098240) 's Twitter Profile Photo

Just in from our group..Severe Autoimmune intravascular hemolytic anemia in patients receiving Alemtuzumab for Multiple sclerosis ashpublications.org/bloodadvances/…

Parth Desai (@parthde93098240) 's Twitter Profile Photo

Why is hyper-fractionation of Cyclophosphamide is done in some aggr. leukemia/lymphomas ? First tried in Burkitt's Lymphoma -pubmed.ncbi.nlm.nih.gov/3491184/ -considering t1/2 of Cycloph. & doubling rate of Burkitt cells to maximize highest dose exposure of active metabolites to cells